Therefore, major efforts have been directed toward finding means to augment the engraftment potential of myoblasts, or seeking additional expandable myogenic cell types that can efficiently restore dystrophin expression in vivo following intramuscular injection in DMD animal models (14–16). Here, DMD is linked to Duchenne muscular dystrophy.